UniProt ID | NHRF1_MOUSE | |
---|---|---|
UniProt AC | P70441 | |
Protein Name | Na(+)/H(+) exchange regulatory cofactor NHE-RF1 | |
Gene Name | Slc9a3r1 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 355 | |
Subcellular Localization |
Cytoplasm. Apical cell membrane. Cell projection, filopodium. Cell projection, ruffle. Cell projection, microvillus. Endomembrane system Peripheral membrane protein. Colocalizes with actin in microvilli-rich apical regions of the syncytiotrophoblast |
|
Protein Description | Scaffold protein that connects plasma membrane proteins with members of the ezrin/moesin/radixin family and thereby helps to link them to the actin cytoskeleton and to regulate their surface expression. Necessary for recycling of internalized ADRB2. Was first known to play a role in the regulation of the activity and subcellular location of SLC9A3. Necessary for cAMP-mediated phosphorylation and inhibition of SLC9A3. May enhance Wnt signaling (By similarity). May participate in HTR4 targeting to microvilli. Involved in the regulation of phosphate reabsorption in the renal proximal tubules (By similarity). Involved in sperm capacitation. May participate in the regulation of the chloride and bicarbonate homeostasis in spermatozoa.. | |
Protein Sequence | MSADAAAGEPLPRLCCLEKGPNGYGFHLHGEKGKVGQFIRLVEPGSPAEKSGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPETDERLKKLGVSIREELLRPQEKSEQAEPPAAADTHEAGDQNEAEKSHLRELRPRLCTMKKGPNGYGFNLHSDKSKPGQFIRAVDPDSPAEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIKGGGDEAKLLVVDKETDEFFKKCKVIPSQEHLDGPLPEPFSNGEIQKESSREALVEPASESPRPALARSASSDTSEELNSQDSPKRQVSTEPSSTSSSSSDPILDLNISLAVAKERAHQKRSSKRAPQMDWSKKNELFSNL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSADAAAGE ------CCCCCCCCC | 34.55 | 26824392 | |
2 | Acetylation | ------MSADAAAGE ------CCCCCCCCC | 34.55 | - | |
34 | Ubiquitination | HLHGEKGKVGQFIRL EEECCCCCCEEEEEE | 55.02 | - | |
34 | Malonylation | HLHGEKGKVGQFIRL EEECCCCCCEEEEEE | 55.02 | 26320211 | |
46 | Phosphorylation | IRLVEPGSPAEKSGL EEEECCCCHHHHCCC | 31.49 | 29176673 | |
50 | Ubiquitination | EPGSPAEKSGLLAGD CCCCHHHHCCCCCCC | 52.51 | 22790023 | |
69 | Ubiquitination | VNGENVEKETHQQVV ECCCCCCHHHHHHHH | 64.73 | 22790023 | |
77 | Phosphorylation | ETHQQVVSRIRAALN HHHHHHHHHHHHHHH | 24.12 | 20200151 | |
101 | Ubiquitination | ETDERLKKLGVSIRE CCHHHHHHHCCCHHH | 55.88 | 22790023 | |
105 | Phosphorylation | RLKKLGVSIREELLR HHHHHCCCHHHHHHC | 17.71 | 28285833 | |
116 | Ubiquitination | ELLRPQEKSEQAEPP HHHCHHHHHHCCCCC | 54.79 | 22790023 | |
117 | Phosphorylation | LLRPQEKSEQAEPPA HHCHHHHHHCCCCCC | 33.90 | 25521595 | |
128 | Phosphorylation | EPPAAADTHEAGDQN CCCCCCCCCCCCCCC | 19.52 | 20415495 | |
139 | Ubiquitination | GDQNEAEKSHLRELR CCCCHHHHHHHHHHH | 50.66 | 22790023 | |
169 | Ubiquitination | NLHSDKSKPGQFIRA CCCCCCCCCCCEEEE | 59.93 | 22790023 | |
181 | Phosphorylation | IRAVDPDSPAEASGL EEEECCCCHHHHCCC | 31.25 | 29176673 | |
201 | S-palmitoylation | IVEVNGVCMEGKQHG EEEECCEEECCCCCC | 1.86 | 28526873 | |
215 | Ubiquitination | GDVVSAIKGGGDEAK CCCEEEEECCCCCEE | 51.74 | - | |
215 | Malonylation | GDVVSAIKGGGDEAK CCCEEEEECCCCCEE | 51.74 | 26320211 | |
228 | Acetylation | AKLLVVDKETDEFFK EEEEEEECCHHHHHH | 51.40 | 21728379 | |
228 | Ubiquitination | AKLLVVDKETDEFFK EEEEEEECCHHHHHH | 51.40 | 22790023 | |
235 | Acetylation | KETDEFFKKCKVIPS CCHHHHHHHCCCCCC | 63.68 | 21728379 | |
255 | Phosphorylation | GPLPEPFSNGEIQKE CCCCCCCCCCCCCCC | 55.42 | 25195567 | |
261 | Ubiquitination | FSNGEIQKESSREAL CCCCCCCCCHHCHHH | 66.29 | 22790023 | |
263 | Phosphorylation | NGEIQKESSREALVE CCCCCCCHHCHHHCC | 41.55 | 25521595 | |
264 | Phosphorylation | GEIQKESSREALVEP CCCCCCHHCHHHCCC | 34.92 | 27087446 | |
273 | Phosphorylation | EALVEPASESPRPAL HHHCCCCCCCCCHHH | 49.69 | 25521595 | |
275 | Phosphorylation | LVEPASESPRPALAR HCCCCCCCCCHHHHH | 24.58 | 27087446 | |
283 | Phosphorylation | PRPALARSASSDTSE CCHHHHHCCCCCCHH | 27.22 | 27087446 | |
285 | Phosphorylation | PALARSASSDTSEEL HHHHHCCCCCCHHHH | 29.96 | 27087446 | |
286 | Phosphorylation | ALARSASSDTSEELN HHHHCCCCCCHHHHH | 44.62 | 24925903 | |
288 | Phosphorylation | ARSASSDTSEELNSQ HHCCCCCCHHHHHCC | 39.73 | 25521595 | |
289 | Phosphorylation | RSASSDTSEELNSQD HCCCCCCHHHHHCCC | 33.78 | 25521595 | |
294 | Phosphorylation | DTSEELNSQDSPKRQ CCHHHHHCCCCCCCC | 48.25 | 25521595 | |
297 | Phosphorylation | EELNSQDSPKRQVST HHHHCCCCCCCCCCC | 25.37 | 24925903 | |
303 | Phosphorylation | DSPKRQVSTEPSSTS CCCCCCCCCCCCCCC | 20.79 | 26239621 | |
304 | Phosphorylation | SPKRQVSTEPSSTSS CCCCCCCCCCCCCCC | 53.73 | 23984901 | |
307 | Phosphorylation | RQVSTEPSSTSSSSS CCCCCCCCCCCCCCC | 39.76 | 23984901 | |
308 | Phosphorylation | QVSTEPSSTSSSSSD CCCCCCCCCCCCCCC | 42.92 | 23984901 | |
309 | Phosphorylation | VSTEPSSTSSSSSDP CCCCCCCCCCCCCCC | 36.64 | 23984901 | |
310 | Phosphorylation | STEPSSTSSSSSDPI CCCCCCCCCCCCCCE | 30.12 | 23984901 | |
311 | Phosphorylation | TEPSSTSSSSSDPIL CCCCCCCCCCCCCEE | 34.04 | 23984901 | |
312 | Phosphorylation | EPSSTSSSSSDPILD CCCCCCCCCCCCEEH | 33.36 | 23984901 | |
313 | Phosphorylation | PSSTSSSSSDPILDL CCCCCCCCCCCEEHH | 40.48 | 23984901 | |
314 | Phosphorylation | SSTSSSSSDPILDLN CCCCCCCCCCEEHHH | 49.72 | 23984901 | |
347 | Malonylation | APQMDWSKKNELFSN CCCCCHHHHHHHHHC | 56.20 | 26320211 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NHRF1_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NHRF1_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SL9A3_HUMAN | SLC9A3 | physical | 14580213 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Specific phosphopeptide enrichment with immobilized titanium ionaffinity chromatography adsorbent for phosphoproteome analysis."; Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.; J. Proteome Res. 7:3957-3967(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-283, AND MASSSPECTROMETRY. | |
"Large-scale phosphorylation analysis of mouse liver."; Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-283; SER-285; SER-286;SER-289 AND SER-297, AND MASS SPECTROMETRY. | |
"Qualitative and quantitative analyses of protein phosphorylation innaive and stimulated mouse synaptosomal preparations."; Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D.,Gerrits B., Panse C., Schlapbach R., Mansuy I.M.; Mol. Cell. Proteomics 6:283-293(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-275 AND SER-285, ANDMASS SPECTROMETRY. | |
"Protein phosphorylation and expression profiling by Yin-yangmultidimensional liquid chromatography (Yin-yang MDLC) massspectrometry."; Dai J., Jin W.-H., Sheng Q.-H., Shieh C.-H., Wu J.-R., Zeng R.; J. Proteome Res. 6:250-262(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-289 AND SER-297, ANDMASS SPECTROMETRY. | |
"Phosphoproteome analysis of mouse liver using immobilized metalaffinity purification and linear ion trap mass spectrometry."; Jin W.-H., Dai J., Zhou H., Xia Q.-C., Zou H.-F., Zeng R.; Rapid Commun. Mass Spectrom. 18:2169-2176(2004). Cited for: PHOSPHORYLATION AT SER-286. |